Back

Serum sLOX-1 concentrations are associated with 2- year major adverse cardiovascular and cerebrovascular events in patients after percutaneous coronary intervention: A multicenter pilot study

1 September 2019 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 2 - Acute Coronary Syndromes: Biomarkers Biomarkers ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Zi-Wen Zhao

Union Hospital, Fujian Medical University,, Fuzhou (China)

6 More presentations in this session

Presentation thumbnail
Professor D. Harrington (Irvine, US)
Abstract Slides
Presentation thumbnail
Ms R. Hoogeveen (Amsterdam, NL)
Abstract
Presentation thumbnail
Professor C. Pemberton (Christchurch, NZ)
Abstract
Presentation thumbnail
Doctor M. Lehrke (Aachen, DE)
Abstract
Presentation thumbnail
Doctor K. watthanasuntorn (Cooperstown, US)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2 - Acute Coronary Syndromes: Biomarkers

The Event

Event poster

ESC Congress 2019

1 September 2019 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources